Machado Patrick Insider Trades

Insider Trading History

Track insider trading activity for Machado Patrick. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$262k 60,020 shares
$4.36
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$38.4k 8,818 shares
$4.36
$4.36
Alumis
Alumis ALMS
Director
Holding Value $1.22M 49,800 shares
Last Trade
Jul 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 49,800 shares
$4.10
$24.51
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $45.6k 10,450 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.5k 13,590 shares
$2.32
$4.36
Arcus Biosciences
Arcus Biosciences RCUS
Director
Holding Value $1.09M 38,600 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384k 38,300 shares
$10.02
$28.18
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $929k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$54.61
Alumis
Alumis ALMS
Director
Holding Value $1.09M 44,364 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$623k 130,384 shares
$4.78
$24.51
Acelyrin
Acelyrin SLRN
Director
Holding Value $0 0 shares
Last Trade
May 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$550k 242,174 shares
$2.27
$2.27
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $45.9k 10,520 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 13,820 shares
$7.32
$4.36
Arcus Biosciences
Arcus Biosciences RCUS
Director
Holding Value $713k 25,300 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 24,000 shares
$15.90
$28.18
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $849k 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$54.61
Acelyrin
Acelyrin SLRN
Director
Holding Value $33.3k 14,675 shares
Last Trade
Oct 04, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$139k 14,675 shares
$9.47
$2.27
Arcus Biosciences
Arcus Biosciences RCUS
Director
Holding Value $550k 19,500 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 19,500 shares
$19.60
$28.18
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $229k 52,500 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81.9k 52,500 shares
$1.56
$4.36
Chimerix
Chimerix CMRX
Director
Holding Value $512k 60,000 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.4k 60,000 shares
$1.39
$8.54
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.01M 18,475 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$720k 18,475 shares
$38.96
$54.61
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $0 0 shares
Last Trade
Aug 17, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.28M 30,000 shares
$76.01
$75.49
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $983k 18,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 18,000 shares
$30.11
$54.61
Chimerix
Chimerix CMRX
Director
Holding Value $427k 50,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91k 50,000 shares
$1.82
$8.54
Arcus Biosciences
Arcus Biosciences RCUS
Director
Holding Value $473k 16,800 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 16,800 shares
$20.62
$28.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up